Evidence map›Paper›PMID 42406719›Full record

ArticlePloS one2026

Research on robot path tracking method based on IDDPG-MPC.

Haicheng Shen, Xun Xu, Zhiqiang Miao

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haicheng ShenSchool of Yonyou Digital and Intelligence, Nantong Institute of Technology, Nantong, Jiangsu, China.ORCID https://orcid.org/0009-0007-0961-5457
Xun XuJiangsu Xinneng Haili Offshore Wind Power Generation Co.Ltd., Nantong, Jiangsu, China.
Zhiqiang MiaoSchool of Yonyou Digital and Intelligence, Nantong Institute of Technology, Nantong, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In complex marine environments, path-following control of unmanned surface vessels (USVs) faces numerous challenges, including environmental disturbances, dynamic nonlinearities, and underactuated systems. To overcome the limitations of traditional line-of-sight/PID control in terms of robustness and adaptability, this study proposes a hybrid control architecture combining improved deep deterministic policy gradient (IDDPG) and model predictive control (MPC). The IDDPG algorithm, as the upper-level decision-making module, utilizes deep reinforcement learning to generate optimal heading angle increment commands by learning the environmental state. The MPC, as the lower-level execution module, optimizes control variables such as thrust and rudder angle through rolling optimization based on the USV's three-degree-of-freedom nonlinear dynamics model. This study constructs a closed-loop "perception-decision-execution-learning" paradigm and employs gradient pruning and a customized reward function to ensure the stability of algorithm training and the optimality of control decisions. Lateral deviation and heading angle error are used as evaluation metrics to verify the control performance. Simulation results show that this method effectively solves the adaptability challenge of traditional control strategies in complex environments. Compared with the traditional ALOS-PID method, the average lateral deviation is reduced by 37% and the heading angle error is reduced by 21%, thus realizing high-precision path tracking control for unmanned surface vessels and providing a new method for autonomous surface vehicle navigation.

Indexed as

RoboticsAlgorithmsComputer SimulationReinforcement Machine Learning

Identifiers

PMID42406719
PMCPMC13336202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.